Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Dynamic42 GmbH currently faces 2 pending office actions in the Chemistry & Materials technology area. The portfolio involves 2 distinct examiners and a matching number of distinct art units, suggesting that the workload is split between different review groups. This structure indicates that the company's technical developments are being assessed from multiple perspectives within the patent office.
ABEL, LENORA A is the busiest examiner, holding 1 pending office action. This indicates that the pending office actions are shared among the distinct examiners assigned to the company's matters. For the practitioner, this decentralized approach means that the outcomes of the prosecution are not tied to a single individual. The use of multiple art units for these filings suggests a breadth of technical subject matter that requires specialized expertise across different examination divisions.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 2 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HASSAN, LIBAN M | 1 | 51.1% | +30.4% |
| ABEL, LENORA A | 1 | 68.9% | +33.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18469397 | CELL CULTURE CHAMBER AND METHOD FOR CULTURING CELLS AND FOR THE IN VITRO PRODUCTION OF CELL LAYERS AND ORGAN MODELS | HASSAN, LIBAN M | — |
| 18469439 | BASE ELEMENT OF A MULTI-CHAMBER BIOCHIP, PRODUCTION OF THE MULTI-CHAMBER BIOCHIP, AND USE THEREOF FOR ESTABLISHING ORGAN AND DISEASE MODELS AND SUBSTANCE TESTS | ABEL, LENORA A | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18469397 | CELL CULTURE CHAMBER AND METHOD FOR CULTURING CELLS AND FOR THE IN VITRO PRODUCTION OF CELL LAYERS AND ORGAN MODELS | HASSAN, LIBAN M | — |
| 18469439 | BASE ELEMENT OF A MULTI-CHAMBER BIOCHIP, PRODUCTION OF THE MULTI-CHAMBER BIOCHIP, AND USE THEREOF FOR ESTABLISHING ORGAN AND DISEASE MODELS AND SUBSTANCE TESTS | ABEL, LENORA A | — |
| Art Unit | Apps |
|---|---|
| 1653 | 1 |
| 1799 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18469397 | CELL CULTURE CHAMBER AND METHOD FOR CULTURING CELLS AND FOR THE IN VITRO PRODUCTION OF CELL LAYERS AND ORGAN MODELS | HASSAN, LIBAN M | 1653 | §103§112 | Non-Final OA | — | Pending | Sep 18, 2023 |
| 18469439 | BASE ELEMENT OF A MULTI-CHAMBER BIOCHIP, PRODUCTION OF THE MULTI-CHAMBER BIOCHIP, AND USE THEREOF FOR ESTABLISHING ORGAN AND DISEASE MODELS AND SUBSTANCE TESTS | ABEL, LENORA A | 1799 | §102§112 | Non-Final OA | — | Pending | Sep 18, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialDynamic42 GmbH has 2 pending office actions as of November 2026, spread across 2 art units and 2 examiners.
Liban M Hassan has the most, with 1 of Dynamic42 GmbH's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.